Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Aug 16 2019

Full Issue

Using International Drug Pricing Remains 'Top Priority' In Trump Administration's Plan To Lower Costs: Verma

Centers for Medicare and Medicaid Services Administrator Seema Verma says that her agency will move forward with plans to tie the prices of certain drugs bought by Medicare to lower prices paid in other countries, known as the International Price Index. Some Republican lawmakers oppose the idea, as does the politically powerful pharmaceutical industry. In other drug pricing news; Democrats push for more negotiating power for Medicare; Sen. Martha McSally listens to constituent complaints; and CVS is slammed online by consumers for its new reimbursement rates for home-delivered birth control.

The Hill: Trump Health Official: Controversial Drug Pricing Move Is 'Top Priority'

A top Trump administration health official on Thursday indicated that the administration is pushing forward with a controversial proposal to lower drug prices, despite opposition from some fellow Republicans. Centers for Medicare and Medicaid Services Administrator Seema Verma told reporters that the proposal to lower certain drug prices in Medicare by tying them to lower prices in other countries, known as the International Price Index, is a “top priority.” (Sullivan, 8/15)

CQ: Details Fuzzy On Democrats' Push For Medicare Drug Negotiation

As Democrats push to let Medicare negotiate prescription drug prices with manufacturers in hopes of lower prices, details of how that system would operate in tandem with private Part D plans are far from settled. The issue is gaining steam as the 2020 elections approach, with the party trying to locate middle ground between its progressive faction and the more moderate majority. (Clason, 8/16)

Arizona Republic: McSally Still 'Looking For Ways' To Reduce Prescription Drug Costs

Workers at a Phoenix pharmacy on Thursday told Sen. Martha McSally that patients routinely leave without their medication because they can't afford it. The reason is cost — high insurance co-pays, insurance denials, and the high price of the drugs themselves. (Innes, 8/15)

The Hill: #CVSDeniesCare Trends Over Plans To Cut Reimbursement Rates For Mail-Order Birth Control 

The hashtag "CVSDeniesCare" began trending on Twitter on Thursday over reports that reimbursement changes for mail-order services could threaten women's access to birth control. The phrase was trending nationally with more than 37,000 tweets after it was reported that CVS Caremark will be cutting reimbursement rates for customers who get birth control delivered straight to their doors. (Gstalter, 8/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF